User profiles for "author:I. Dolgalev"
Igor DolgalevNew York University School of Medicine Verified email at nyulangone.org Cited by 16069 |
[PDF][PDF] Integrative genomic profiling of human prostate cancer
Annotation of prostate cancer genomes provides a foundation for discoveries that can
impact disease understanding and treatment. Concordant assessment of DNA copy number …
impact disease understanding and treatment. Concordant assessment of DNA copy number …
[HTML][HTML] Prognostic relevance of integrated genetic profiling in acute myeloid leukemia
…, P Van Vlierberghe, I Dolgalev… - … England Journal of …, 2012 - Mass Medical Soc
Background Acute myeloid leukemia (AML) is a heterogeneous disease with respect to
presentation and clinical outcome. The prognostic value of recently identified somatic …
presentation and clinical outcome. The prognostic value of recently identified somatic …
[HTML][HTML] Mutations in GNA11 in Uveal Melanoma
…, R Roy, A Heguy, I Dolgalev… - … England Journal of …, 2010 - Mass Medical Soc
Background Uveal melanoma is the most common intraocular cancer. There are no effective
therapies for metastatic disease. Mutations in GNAQ, the gene encoding an alpha subunit of …
therapies for metastatic disease. Mutations in GNAQ, the gene encoding an alpha subunit of …
The bone marrow microenvironment at single-cell resolution
The bone marrow microenvironment has a key role in regulating haematopoiesis, but its
molecular complexity and response to stress are incompletely understood. Here we map the …
molecular complexity and response to stress are incompletely understood. Here we map the …
[PDF][PDF] Restoration of TET2 function blocks aberrant self-renewal and leukemia progression
Loss-of-function mutations in TET2 occur frequently in patients with clonal hematopoiesis,
myelodysplastic syndrome (MDS), and acute myeloid leukemia (AML) and are associated …
myelodysplastic syndrome (MDS), and acute myeloid leukemia (AML) and are associated …
[HTML][HTML] Connecting the dots: resolving the bone marrow niche heterogeneity
I Dolgalev, AN Tikhonova - Frontiers in cell and developmental …, 2021 - frontiersin.org
Single-cell sequencing approaches have transformed our understanding of stem cell
systems, including hematopoiesis and its niche within the bone marrow. Recent reports …
systems, including hematopoiesis and its niche within the bone marrow. Recent reports …
Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies
…, K Huberman, S Thomas, I Dolgalev… - Blood, The Journal …, 2009 - ashpublications.org
Disease alleles that activate signal transduction are common in myeloid malignancies;
however, there are additional unidentified mutations that contribute to myeloid …
however, there are additional unidentified mutations that contribute to myeloid …
Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis
…, CJ Thomas, C Goparaju, A Davies, I Dolgalev… - Nature medicine, 2017 - nature.com
Treating KRAS-mutant lung adenocarcinoma (LUAD) remains a major challenge in cancer
treatment given the difficulties associated with directly inhibiting the KRAS oncoprotein. One …
treatment given the difficulties associated with directly inhibiting the KRAS oncoprotein. One …
The mutational landscape of adenoid cystic carcinoma
…, LA Walsh, S Eng, JT Huse, J Zhang, I Dolgalev… - Nature …, 2013 - nature.com
Adenoid cystic carcinomas (ACCs) are among the most enigmatic of human malignancies.
These aggressive salivary gland cancers frequently recur and metastasize despite definitive …
These aggressive salivary gland cancers frequently recur and metastasize despite definitive …
The integrated landscape of driver genomic alterations in glioblastoma
Glioblastoma is one of the most challenging forms of cancer to treat. Here we describe a
computational platform that integrates the analysis of copy number variations and somatic …
computational platform that integrates the analysis of copy number variations and somatic …